Spots Global Cancer Trial Database for Immunomonitoring of Breast Cancer Patients During Systemic Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Immunomonitoring of Breast Cancer Patients During Systemic Treatment
Official Title: Immunomonitoring of Breast Cancer Patients During Systemic Treatment
Study ID: NCT04925856
Conditions
Interventions
Study Description
Brief Summary: This study aims to constitute a most complete biological collection for patients treated for localized or metastatic breast cancer (in different cohorts depending on the type of systemic treatment received), in order to describe the basal immune response of patients treated for a breast cancer according to the stage of the disease, but above all to study how the different systemic treatments used in the management of breast cancer modulate this immune response.
Detailed Description: The main objective of this study is to describe, depending on the type of systemic treatment received, the blood immune response before treatment and its evolution under treatment.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
CHRU Jean Minjoz, Besançon, , France
Centre Georges Francois Leclerc, Dijon, , France
Contact Details
Name: Sylvain LADOIRE, PU-PH
Affiliation: Centre Georges François Leclerc
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
